Safety of trifluridine/tipiracil for metastatic colorectal cancer in African American patients participating in an expanded access program.

被引：0
|
作者：
Philip, Philip Agop
Smaglo, Brandon George
El-Rayes, Bassel F.
Lesuisse, Christian
Makris, Lukas
机构：
[1] Karmanos Canc Inst, Detroit, MI USA
[2] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
[3] Emory Univ, Winship Canc Inst, Dept Med Oncol, Atlanta, GA 30322 USA
[4] Taiho Oncol Inc, Princeton, NJ USA
[5] Stathmi Inc, New Hope, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15039
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15039
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer
    Mayer, Robert J.
    Hochster, Howard S.
    Cohen, Steven J.
    Winkler, Robert
    Makris, Lukas
    Grothey, Axel
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (06) : 961 - 969
  • [2] Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer
    Robert J. Mayer
    Howard S. Hochster
    Steven J. Cohen
    Robert Winkler
    Lukas Makris
    Axel Grothey
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 961 - 969
  • [3] The safety of trifluridine and tipiracil for the treatment of metastatic colorectal cancer
    Martinez-Perez, Julia
    Carmen Riesco-Martinez, M.
    Garcia-Carbonero, Rocio
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (06) : 643 - 650
  • [4] An open-label expanded access study of trifluridine/tipiracil for metastatic colorectal cancer.
    Mayer, Robert J.
    Grothey, Axel
    Hochster, Howard S.
    Cohen, Steven J.
    Vukovic, Vojislav M.
    Makris, Lukas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Safety and efficacy of trifluridine/tipiracil monotherapy in metastatic colorectal cancer
    Aparicio Rubio, C.
    Monteagudo Santolaya, E.
    Cornejo Uixeda, S.
    Prieto Castello, M.
    Antonino de la Camara, G.
    Quintana Vergara, B.
    Sanchez Alcaraz, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 373 - 374
  • [6] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Yoshiaki Fujimoto
    Ryota Nakanishi
    Mamoru Nukatsuka
    Kazuaki Matsuoka
    Koji Ando
    Takeshi Wakasa
    Hiroyuki Kitao
    Eiji Oki
    Yoshihiko Maehara
    Masaki Mori
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 1029 - 1038
  • [7] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Fujimoto, Yoshiaki
    Nakanishi, Ryota
    Nukatsuka, Mamoru
    Matsuoka, Kazuaki
    Ando, Koji
    Wakasa, Takeshi
    Kitao, Hiroyuki
    Oki, Eiji
    Maehara, Yoshihiko
    Mori, Masaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (06) : 1029 - 1038
  • [8] Safety of trifluridine/tipiracil (FTD/TPI) in elderly patients with metastatic colorectal cancer.
    Mayer, Robert J.
    Hochster, Howard S.
    Cohen, Steven J.
    Winkler, Robert
    Makris, Lukas
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [9] Effectiveness and safety of trifluridine/tipiracil in patients with metastatic colorectal cancer in clinical practice in Poland
    Radecka, B.
    Gelej, M.
    Streb, J.
    Siedlaczek, A.
    Kryka, K.
    Tokajuk, P.
    Winsko-Szczesnowicz, K.
    Czernek, U.
    Sobczak, M.
    Malik, M.
    Bodnar, L.
    Foszczynska-Kloda, M.
    Hetman, K.
    Skiewicz, M. Welnicka-Ja
    Wierzbicka, K.
    Orlikowska, M.
    Becht, R.
    Deptala, A.
    Itrych, B.
    Kania-Zembaczynska, B.
    ANNALS OF ONCOLOGY, 2020, 31 : S108 - S108
  • [10] Trifluridine/Tipiracil: A Review in Metastatic Colorectal Cancer
    Celeste B. Burness
    Sean T. Duggan
    Drugs, 2016, 76 : 1393 - 1402
12345